1Meng X, Mojaverian P, Doedee M, et al. Bioavailability of amiodarone tablets administered with and without food in healthy subjects[J ]. Am J Cardiol, 2001, 87 (4) : 432 - 435.
2Naccarelli GV ,Wolbrette DL. Amiodarone:what have we learned from clinical trials? [ J ]. Clin Cardiol, 2000,23 (2) : 73 - 82.
3Sim I, Mc Donald K M, Lavori PW,et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death[J ]. Circulation, 1997,96(9):2 823 - 2 829.
4Chin C, Feindel C, Cheng D. Duration of preoperative amiodarone treatment maybe associated with postoperative hospital mortality in patients undergoing heart transplantation [J ]. J Cardiothorac Vasc Anesth, 1999,13 (5) : 562 -566.
5Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure[J ]. N Engl J Med, 1995,333 (2) : 77 - 82.
6Podrid PJ. Amiodarone : reevaluation of an old drug [ J ]. Ann Intern Med,1995,122(9) :689 - 700.
7Toft AD, Boon NA. Thyroid disease and the heart [ J ]. Heart, 2000,84 (4) :455 - 460.
8Latorre G, Lucas I, Herrero JI, et al. Severe hepatotoxicity caused by amiodarone :description of a case[J]. Rev Med Univ Navarra, 1999,43(2) :86 -91.
9Yonezawa E, Matsumoto K, Ueno K, et al. Lack of interaction between amiodarone and mexiletine in cardiac arrhythmia patients [J ]. J Clin Pharmacol, 2002,42 (3) : 342 - 346.
10Boutitie F, Boissel JP, Connolly SJ, et al. Amiodarone interaction with beta - blockers : analysis of the merged EMIAT ( European Myocardial Infarct Amiodarone Trial)and CAMIAT(Canadian Amiodarone Myocardial Infarction Trial ) databases. The EMIAT and CAMIAT Investigators [ J ].Circulation, 1999,99(17) :2 268 - 2 275.
